Possible Path to Treatment
(BASEL, SWITZERLAND) Roche Holding, Ltd and Decode Genetics Inc. announced that they have identified a gene that, in mutated version, predisposes carriers to develop the most common form of Alzheimer's disease: late-onset. Other genes in mutated form have also been linked to both early and late-onset Alzheimer's disease in recent years. This latest finding may help to better understand the disease and develop diagnostic tests to identify those at risk.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.